These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 11808338)

  • 21. The use of animal models in expression pharmacogenomic analyses.
    Rothberg BE
    Pharmacogenomics J; 2001; 1(1):48-58. PubMed ID: 11913726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High throughput analysis of differential gene expression.
    Carulli JP; Artinger M; Swain PM; Root CD; Chee L; Tulig C; Guerin J; Osborne M; Stein G; Lian J; Lomedico PT
    J Cell Biochem; 1998; 72 Suppl 30-31(S30-31):286-296. PubMed ID: 29345813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of industrial scale genomics to discovery of therapeutic targets in heart failure.
    Mehraban F; Tomlinson JE
    Eur J Heart Fail; 2001 Dec; 3(6):641-50. PubMed ID: 11738215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Candidate gene selection in pharmacogenomics: biology leads the way.
    Watters JW; McLeod HL
    Pharmacogenomics; 2004 Dec; 5(8):1019-22. PubMed ID: 15584871
    [No Abstract]   [Full Text] [Related]  

  • 25. Ho et al. respond.
    Ho TL; Fulco JR; Schrieffer JR; Wilczek F
    Phys Rev Lett; 1985 Apr; 54(13):1462. PubMed ID: 10031042
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparing the use of Affymetrix to spotted oligonucleotide microarrays using two retinal pigment epithelium cell lines.
    Rogojina AT; Orr WE; Song BK; Geisert EE
    Mol Vis; 2003 Oct; 9():482-96. PubMed ID: 14551534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic gene clusters as drug action mechanisms].
    Tanaka T
    Nihon Yakurigaku Zasshi; 2003 Nov; 122 Suppl():5P-7P. PubMed ID: 14727507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacogenomics: the frontiers of genome medicine].
    Tanaka T; Tsujimoto G; Sugiyama Y; Hashimoto Y
    Nihon Yakurigaku Zasshi; 2002 Sep; 120(3):141-8. PubMed ID: 12271509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenomics and therapeutic target validation in cerebral vasospasm.
    Tanaka T; Nishimura Y; Tsunoda H; Naka M
    J Cardiovasc Pharmacol; 2000; 36 Suppl 2():S1-4. PubMed ID: 11206713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenomics of cardiovascular pharmacology: pharmacogenomic network of cardiovascular disease models.
    Tanaka T; Oka T; Shimada Y; Umemoto N; Kuroyanagi J; Sakamoto C; Zang L; Wang Z; Nishimura Y
    J Pharmacol Sci; 2008 May; 107(1):8-14. PubMed ID: 18490853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacogenomics and pharmainformatics].
    Tanaka T; Nishimura Y; Tsunoda H; Kitaoka Y; Naka M
    Nihon Rinsho; 2002 Jan; 60(1):39-50. PubMed ID: 11808338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Transcriptome analysis and pharmacogenomics].
    Tanaka T
    Nihon Yakurigaku Zasshi; 2000 Oct; 116(4):241-6. PubMed ID: 11084921
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.